Logo image of CNK

CINEMARK HOLDINGS INC (CNK) Stock Fundamental Analysis

NYSE:CNK - New York Stock Exchange, Inc. - US17243V1026 - Common Stock - Currency: USD

33.77  +0.81 (+2.46%)

After market: 33.77 0 (0%)

Fundamental Rating

4

Taking everything into account, CNK scores 4 out of 10 in our fundamental rating. CNK was compared to 72 industry peers in the Entertainment industry. CNK has an excellent profitability rating, but there are concerns on its financial health. CNK has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CNK had positive earnings in the past year.
In the past year CNK had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CNK reported negative net income in multiple years.
CNK had a positive operating cash flow in 4 of the past 5 years.
CNK Yearly Net Income VS EBIT VS OCF VS FCFCNK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

CNK's Return On Assets of 5.16% is amongst the best of the industry. CNK outperforms 83.10% of its industry peers.
CNK has a better Return On Equity (69.13%) than 95.77% of its industry peers.
The Return On Invested Capital of CNK (7.83%) is better than 80.28% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CNK is significantly below the industry average of 22.66%.
The 3 year average ROIC (5.91%) for CNK is below the current ROIC(7.83%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.16%
ROE 69.13%
ROIC 7.83%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
CNK Yearly ROA, ROE, ROICCNK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

CNK's Profit Margin of 8.02% is amongst the best of the industry. CNK outperforms 84.51% of its industry peers.
CNK's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 10.66%, CNK belongs to the best of the industry, outperforming 80.28% of the companies in the same industry.
CNK's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 64.38%, CNK is in the better half of the industry, outperforming 73.24% of the companies in the same industry.
CNK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.66%
PM (TTM) 8.02%
GM 64.38%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
CNK Yearly Profit, Operating, Gross MarginsCNK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

CNK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CNK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CNK has more shares outstanding
CNK has a better debt/assets ratio than last year.
CNK Yearly Shares OutstandingCNK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CNK Yearly Total Debt VS Total AssetsCNK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.27, we must say that CNK is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CNK (1.27) is comparable to the rest of the industry.
CNK has a debt to FCF ratio of 11.16. This is a negative value and a sign of low solvency as CNK would need 11.16 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 11.16, CNK is in line with its industry, outperforming 54.93% of the companies in the same industry.
CNK has a Debt/Equity ratio of 5.66. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 5.66, CNK is doing worse than 77.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.66
Debt/FCF 11.16
Altman-Z 1.27
ROIC/WACC0.85
WACC9.25%
CNK Yearly LT Debt VS Equity VS FCFCNK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

CNK has a Current Ratio of 0.79. This is a bad value and indicates that CNK is not financially healthy enough and could expect problems in meeting its short term obligations.
CNK has a Current ratio (0.79) which is comparable to the rest of the industry.
A Quick Ratio of 0.76 indicates that CNK may have some problems paying its short term obligations.
With a Quick ratio value of 0.76, CNK is not doing good in the industry: 60.56% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.76
CNK Yearly Current Assets VS Current LiabilitesCNK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.83% over the past year.
Measured over the past 5 years, CNK shows a small growth in Earnings Per Share. The EPS has been growing by 4.49% on average per year.
The Revenue has decreased by -0.80% in the past year.
Measured over the past years, CNK shows a decrease in Revenue. The Revenue has been decreasing by -1.47% on average per year.
EPS 1Y (TTM)4.83%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%-268.42%
Revenue 1Y (TTM)-0.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%-6.65%

3.2 Future

Based on estimates for the next years, CNK will show a small growth in Earnings Per Share. The EPS will grow by 7.80% on average per year.
Based on estimates for the next years, CNK will show a small growth in Revenue. The Revenue will grow by 6.68% on average per year.
EPS Next Y-18.02%
EPS Next 2Y4.11%
EPS Next 3Y7.8%
EPS Next 5YN/A
Revenue Next Year9.46%
Revenue Next 2Y8.36%
Revenue Next 3Y6.68%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNK Yearly Revenue VS EstimatesCNK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CNK Yearly EPS VS EstimatesCNK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

5

4. Valuation

4.1 Price/Earnings Ratio

CNK is valuated rather expensively with a Price/Earnings ratio of 22.22.
Compared to the rest of the industry, the Price/Earnings ratio of CNK indicates a rather cheap valuation: CNK is cheaper than 81.69% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.25. CNK is around the same levels.
A Price/Forward Earnings ratio of 15.35 indicates a correct valuation of CNK.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CNK indicates a rather cheap valuation: CNK is cheaper than 84.51% of the companies listed in the same industry.
CNK's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.15.
Industry RankSector Rank
PE 22.22
Fwd PE 15.35
CNK Price Earnings VS Forward Price EarningsCNK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNK indicates a somewhat cheap valuation: CNK is cheaper than 77.46% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNK indicates a somewhat cheap valuation: CNK is cheaper than 77.46% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.64
EV/EBITDA 10.7
CNK Per share dataCNK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The decent profitability rating of CNK may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.95
EPS Next 2Y4.11%
EPS Next 3Y7.8%

3

5. Dividend

5.1 Amount

CNK has a yearly dividend return of 0.47%, which is pretty low.
CNK's Dividend Yield is rather good when compared to the industry average which is at 6.59. CNK pays more dividend than 81.69% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, CNK's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.47%

5.2 History

CNK has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNK Yearly Dividends per shareCNK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y4.11%
EPS Next 3Y7.8%
CNK Yearly Income VS Free CF VS DividendCNK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CINEMARK HOLDINGS INC

NYSE:CNK (5/30/2025, 8:04:00 PM)

After market: 33.77 0 (0%)

33.77

+0.81 (+2.46%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners119.94%
Inst Owner Change-2.84%
Ins Owners2.2%
Ins Owner Change-7.46%
Market Cap3.88B
Analysts76
Price Target33.46 (-0.92%)
Short Float %20.41%
Short Ratio5.1
Dividend
Industry RankSector Rank
Dividend Yield 0.47%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date05-29 2025-05-29 (0.08)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-56.93%
Min EPS beat(2)-100.53%
Max EPS beat(2)-13.33%
EPS beat(4)2
Avg EPS beat(4)62.52%
Min EPS beat(4)-100.53%
Max EPS beat(4)254.24%
EPS beat(8)5
Avg EPS beat(8)64.97%
EPS beat(12)6
Avg EPS beat(12)-8.2%
EPS beat(16)7
Avg EPS beat(16)1.09%
Revenue beat(2)1
Avg Revenue beat(2)0.74%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)1.9%
Revenue beat(4)3
Avg Revenue beat(4)2.45%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)5.09%
Revenue beat(8)7
Avg Revenue beat(8)2.96%
Revenue beat(12)10
Avg Revenue beat(12)2.73%
Revenue beat(16)13
Avg Revenue beat(16)6.14%
PT rev (1m)1.23%
PT rev (3m)-3.81%
EPS NQ rev (1m)14.13%
EPS NQ rev (3m)15.9%
EPS NY rev (1m)-6.65%
EPS NY rev (3m)-17.54%
Revenue NQ rev (1m)4.21%
Revenue NQ rev (3m)7.11%
Revenue NY rev (1m)0.87%
Revenue NY rev (3m)-1.39%
Valuation
Industry RankSector Rank
PE 22.22
Fwd PE 15.35
P/S 1.29
P/FCF 17.64
P/OCF 10.51
P/B 11.12
P/tB N/A
EV/EBITDA 10.7
EPS(TTM)1.52
EY4.5%
EPS(NY)2.2
Fwd EY6.52%
FCF(TTM)1.91
FCFY5.67%
OCF(TTM)3.21
OCFY9.52%
SpS26.18
BVpS3.04
TBVpS-10.38
PEG (NY)N/A
PEG (5Y)4.95
Profitability
Industry RankSector Rank
ROA 5.16%
ROE 69.13%
ROCE 9.05%
ROIC 7.83%
ROICexc 9.75%
ROICexgc 21.27%
OM 10.66%
PM (TTM) 8.02%
GM 64.38%
FCFM 7.31%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
ROICexc(3y)7.77%
ROICexc(5y)N/A
ROICexgc(3y)16.27%
ROICexgc(5y)N/A
ROCE(3y)6.83%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y17.77%
ROICexc growth 3YN/A
ROICexc growth 5Y8.59%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
F-Score6
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 5.66
Debt/FCF 11.16
Debt/EBITDA 3.81
Cap/Depr 75.61%
Cap/Sales 4.96%
Interest Coverage 2.19
Cash Conversion 71.26%
Profit Quality 91.22%
Current Ratio 0.79
Quick Ratio 0.76
Altman-Z 1.27
F-Score6
WACC9.25%
ROIC/WACC0.85
Cap/Depr(3y)64.73%
Cap/Depr(5y)52.5%
Cap/Sales(3y)4.78%
Cap/Sales(5y)6.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.83%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%-268.42%
EPS Next Y-18.02%
EPS Next 2Y4.11%
EPS Next 3Y7.8%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%-6.65%
Revenue Next Year9.46%
Revenue Next 2Y8.36%
Revenue Next 3Y6.68%
Revenue Next 5YN/A
EBIT growth 1Y-10.88%
EBIT growth 3YN/A
EBIT growth 5Y-2.31%
EBIT Next Year81.21%
EBIT Next 3Y29.04%
EBIT Next 5YN/A
FCF growth 1Y52.49%
FCF growth 3Y64.6%
FCF growth 5Y4.05%
OCF growth 1Y40.69%
OCF growth 3Y41.01%
OCF growth 5Y-3.68%